Abdallah HM et al (2015) P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J Adv Res 6(1):45–62.
Article
MathSciNet
CAS
PubMed
Google Scholar
Abe T et al (1995) Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Br J Cancer 72(2):418–423.
Article
MathSciNet
CAS
PubMed
PubMed Central
Google Scholar
Abraham I et al (2010) Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Biochem Pharmacol 80(10):1497–1506.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahmed-Belkacem A et al (2005) Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res 65(11):4852–4860.
Article
CAS
PubMed
Google Scholar
Ahmed-Belkacem A et al (2007) Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors. J Med Chem 50(8):1933–1938.
Article
CAS
PubMed
Google Scholar
Anuchapreeda S et al (2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64(4):573–582.
Article
CAS
PubMed
Google Scholar
Aoki S et al (1999) Reversal of multidrug resistance in human carcinoma cell line by agosterols, marine spongean sterols. Tetrahedron 55(49):13965–13972.
Article
CAS
Google Scholar
Aoki S et al (2004) Kendarimide a, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp. Tetrahedron 60(33):7053–7059.
Article
CAS
Google Scholar
Avendaño C, Menéndez JC (2015) Chapter 14 - drugs that modulate resistance to antitumor agents. In: Medicinal chemistry of anticancer drugs (second edition). Elsevier, Boston, pp 655–700.
Chapter
Google Scholar
Bernardes de Andrade Carli C, Quilles MB, Carlos IZ (2013) Chapter 16—natural products with activity against multidrug-resistant tumor cells A2 - Rai, Mahendra Kumar. In: Kon KV (ed) Fighting Multidrug Resistance with Herbal Extracts, Essential Oils and Their Components. Academic Press, San Diego, pp 237–244.
Chapter
Google Scholar
Brooks TA et al (2004) Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators. Anticancer Res 24(2a):409–415.
CAS
PubMed
Google Scholar
Callies O et al (2016) Optimization by molecular fine tuning of Dihydro-beta-agarofuran sesquiterpenoids as reversers of P-glycoprotein-mediated multidrug resistance. J Med Chem 59(5):1880–1890.
Article
CAS
PubMed
Google Scholar
Carlson RW, Sikic BI (1983) Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med 99(6):823–833.
Article
CAS
PubMed
Google Scholar
Chearwae W et al (2004) Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharmacol 68(10):2043–2052.
Article
CAS
PubMed
Google Scholar
Chearwae W et al (2006a) Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol Cancer Ther 5(8):1995–2006.
Article
CAS
PubMed
Google Scholar
Chearwae W et al (2006b) Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol 57(3):376–388.
Article
CAS
PubMed
Google Scholar
Choi CH, Kang G, Min YD (2003) Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 69(3):235–240.
Article
CAS
PubMed
Google Scholar
Choi CH et al (2002) Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3′,4′-pentamethoxyflavone (Sinensetin). Biochem Biophys Res Commun 295(4):832–840.
Article
CAS
PubMed
Google Scholar
Collnot EM et al (2007) Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 4(3):465–474.
Article
CAS
PubMed
Google Scholar
Cooray HC et al (2004) Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun 317(1):269–275.
Article
CAS
PubMed
Google Scholar
Corea G et al (2004) Structure-activity relationships for euphocharacins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein. Planta Med 70(7):657–665.
Article
CAS
PubMed
Google Scholar
de Castro WV et al (2007) Grapefruit juice-drug interactions: grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J Pharm Sci 96(10):2808–2817.
Article
PubMed
CAS
Google Scholar
Dean M, Annilo T (2005) Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6:123–142.
Article
CAS
PubMed
Google Scholar
Doyle LA et al (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95(26):15665–15670.
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Eichhorn T, Efferth T (2012) P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 141(2):557–570.
Article
CAS
PubMed
Google Scholar
Eytan GD (2005) Mechanism of multidrug resistance in relation to passive membrane permeation. Biomed Pharmacother 59(3):90–97.
Article
CAS
PubMed
Google Scholar
Fan L et al (2009) Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers. Ann Pharmacother 43(5):944–949.
Article
CAS
PubMed
Google Scholar
Ferte J (2000) Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur J Biochem 267(2):277–294.
Article
CAS
PubMed
Google Scholar
Fong WF et al (2007) Schisandrol a from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes. Planta Med 73(3):212–220.
Article
CAS
PubMed
Google Scholar
Fromm MF (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25(8):423–429.
Article
CAS
PubMed
Google Scholar
Fu L et al (2004) Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother Pharmacol 53(4):349–356.
Article
MathSciNet
CAS
PubMed
Google Scholar
Gillet J-P, Efferth T, Remacle J (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochimica et Biophysica Acta (BBA) Rev Cancer 1775(2):237–262.
Article
CAS
Google Scholar
Glavinas H et al (2004) The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1(1):27–42.
Article
CAS
PubMed
Google Scholar
Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627.
Article
CAS
PubMed
Google Scholar
Gottesman MM, Ambudkar SV (2001) Overview: ABC transporters and human disease. J Bioenerg Biomembr 33(6):453–458.
Article
CAS
PubMed
Google Scholar
Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48–58.
Article
CAS
PubMed
Google Scholar
Gottesman MM, Ling V (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580(4):998–1009.
Article
CAS
PubMed
Google Scholar
Han Y, Chin Tan TM, Lim LY (2008) In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol Appl Pharmacol 230(3):283–289.
Article
CAS
PubMed
Google Scholar
Hemauer SJ et al (2009) Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. Biochem Pharmacol 78(9):1272–1278.
Article
CAS
PubMed
PubMed Central
Google Scholar
Henrich CJ et al (2006) A high-throughput cell-based assay for inhibitors of ABCG2 activity. J Biomol Screen 11(2):176–183.
Article
CAS
PubMed
Google Scholar
Hohmann J et al (2003) Jatrophane diterpenoids from Euphorbia mongolica as modulators of the multidrug resistance of L5128 mouse lymphoma cells. J Nat Prod 66(7):976–979.
Article
CAS
PubMed
Google Scholar
Holland ML, Allen JD, Arnold JC (2008) Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur J Pharmacol 591(1–3):128–131.
Article
CAS
PubMed
Google Scholar
Holland ML et al (2006) The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem Pharmacol 71(8):1146–1154.
Article
CAS
PubMed
Google Scholar
Holland ML et al (2007) The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. Br J Pharmacol 152(5):815–824.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang Y (2007) Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 26(1):183–201.
Article
CAS
PubMed
Google Scholar
Hyde SC et al (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346(6282):362–365.
Article
ADS
CAS
PubMed
Google Scholar
Ifergan I et al (2004) Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 279(24):25527–25534.
Article
CAS
PubMed
Google Scholar
Imai Y et al (2004) Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64(12):4346–4352.
Article
CAS
PubMed
Google Scholar
Jain S et al (2007) Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids. J Nat Prod 70(6):928–931.
Article
CAS
PubMed
Google Scholar
Jin J et al (2005) Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Cancer Chemother Pharmacol 55(2):179–188.
Article
MathSciNet
CAS
PubMed
Google Scholar
Jin J et al (2006) Metabolites of ginsenosides as novel BCRP inhibitors. Biochem Biophys Res Commun 345(4):1308–1314.
Article
CAS
PubMed
Google Scholar
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152–162.
Article
CAS
PubMed
Google Scholar
Kadioglu O et al (2016) Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: functional and molecular docking analyses. Biochem Pharmacol 104(Supplement C):42–51.
Article
CAS
PubMed
Google Scholar
Karthikeyan S, Hoti SL (2015) Development of fourth generation ABC inhibitors from natural products: a novel approach to overcome cancer multidrug resistance. Anti Cancer Agents Med Chem 15(5):605–615.
Article
CAS
Google Scholar
Katayama K et al (2007) Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. Cancer Chemother Pharmacol 60(6):789–797.
Article
CAS
PubMed
Google Scholar
Kathawala RJ et al (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17.
Kim SW et al (2003) Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol 65(1):75–82.
Article
CAS
PubMed
Google Scholar
Kitagawa S, Nabekura T, Kamiyama S (2004) Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 56(8):1001–1005.
Article
CAS
PubMed
Google Scholar
KKW T et al (2017) Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. J Ethnopharmacol 203(Supplement C):110–119.
Google Scholar
Klinkhammer W et al (2009) Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators. Bioorg Med Chem 17(6):2524–2535.
Article
CAS
PubMed
Google Scholar
Koizumi S et al (1995) Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123. Eur J Cancer 31a(10):1682–1688.
Article
CAS
PubMed
Google Scholar
Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11(4):265–283.
Article
CAS
PubMed
Google Scholar
Krishna R, Mayer LD (2001) Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators. Curr Med Chem Anticancer Agents 1(2):163–174.
Article
CAS
PubMed
Google Scholar
Kuete V, Efferth T (2015) African Flora has the potential to fight multidrug resistance of cancer. Biomed Res Int 2015:24.
Article
Google Scholar
Kyle AH et al (2007) Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res 13(9):2804–2810.
Article
CAS
PubMed
Google Scholar
Lee Y et al (2004) Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring. J Med Chem 47(22):5555–5566.
Article
CAS
PubMed
Google Scholar
Leschziner G et al (2006) Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet Genomics 16(6):439–450.
Article
CAS
PubMed
Google Scholar
Leslie EM et al (2001) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol 59(5):1171–1180.
Article
CAS
PubMed
Google Scholar
Lim S et al (2007) Reversal of P-glycoprotein-mediated drug efflux by eudesmin from Haplophyllum perforatum and cytotoxicity pattern versus diphyllin, podophyllotoxin and etoposide. Planta Med 73(15):1563–1567.
Article
CAS
PubMed
Google Scholar
Limtrakul P, Khantamat O, Pintha K (2004) Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemother Pharmacol 54(6):525–530.
Article
PubMed
Google Scholar
Limtrakul P, Khantamat O, Pintha K (2005) Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 17(1):86–95.
Article
CAS
PubMed
Google Scholar
Limtrakul P et al (2007a) Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells. Phytomedicine 14(6):381–389.
Article
CAS
PubMed
Google Scholar
Limtrakul P et al (2007b) Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296(1–2):85–95.
Article
CAS
PubMed
Google Scholar
Longley DB, Allen WL, Johnston PG (2006) Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta 1766(2):184–196.
CAS
PubMed
Google Scholar
Loo TW, Clarke DM (2005) Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 206(3):173–185.
Article
CAS
PubMed
Google Scholar
Lopez D, Martinez-Luis S (2014) Marine natural products with P-glycoprotein inhibitor properties. Mar Drugs 12(1):525–546.
Article
MathSciNet
PubMed
PubMed Central
CAS
Google Scholar
Ma Y, Wink M (2010) The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells. Phytother Res 24(1):146–149.
Article
CAS
PubMed
Google Scholar
Madureira AM et al (2004a) A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein. Planta Med 70(9):828–833.
Article
CAS
PubMed
Google Scholar
Madureira AM et al (2004b) Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells. Anticancer Res 24(2b):859–864.
CAS
PubMed
Google Scholar
Mahringer A et al (2010) Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics 7(4):191–205.
CAS
PubMed
Google Scholar
Marangolo M et al (2006) Dose and outcome: the hurdle of neutropenia (review). Oncol Rep 16(2):233–248.
CAS
PubMed
Google Scholar
Matsumoto S et al (2011) Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 71(20):6350–6359.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mbaveng AT, Kuete V, Efferth T (2017) Potential of central, eastern and Western Africa medicinal plants for cancer therapy: spotlight on resistant cells and molecular targets. Front Pharmacol 8:343.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mitsuo M et al (2003) Binding site(s) on P-glycoprotein for a newly synthesized photoaffinity analog of agosterol A. Oncol Res 14(1):39–48.
Article
CAS
PubMed
Google Scholar
Morita H et al (2005) Antimitotic activity and reversal of breast cancer resistance protein-mediated drug resistance by stilbenoids from Bletilla striata. Bioorg Med Chem Lett 15(4):1051–1054.
Article
MathSciNet
CAS
PubMed
Google Scholar
Morrow CS et al (2006) Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux. Mol Pharmacol 69(4):1499–1505.
Article
CAS
PubMed
Google Scholar
Munoz-Martinez F et al (2004) Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance. Cancer Res 64(19):7130–7138.
Article
CAS
PubMed
Google Scholar
Nabekura T et al (2008) Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62(5):867–873.
Article
CAS
PubMed
Google Scholar
Nawrath H, Raschack M (1987) Effects of (−)-desmethoxyverapamil on heart and vascular smooth muscle. J Pharmacol Exp Ther 242(3):1090–1097.
CAS
PubMed
Google Scholar
Nie J et al (2016) Efficacy of traditional Chinese medicine in treating cancer. Biomed Rep 4(1):3–14.
Article
CAS
PubMed
Google Scholar
Ooko E et al (2016) Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Toxicol Appl Pharmacol 305(Supplement C):216–233.
Article
CAS
PubMed
Google Scholar
Palmeira A et al (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19(13):1946–2025.
Article
CAS
PubMed
Google Scholar
Palomo C et al (2004) A practical total synthesis of hapalosin, a 12-membered cyclic depsipeptide with multidrug resistance-reversing activity, by employing improved segment coupling and macrolactonization. J Org Chem 69(12):4126–4134.
Article
CAS
PubMed
Google Scholar
Patanasethanont D et al (2007a) Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J Pharm Sci 96(1):223–233.
Article
CAS
PubMed
Google Scholar
Patanasethanont D et al (2007b) Modulation of function of multidrug resistance associated-proteins by Kaempferia parviflora extracts and their components. Eur J Pharmacol 566(1–3):67–74.
Article
CAS
PubMed
Google Scholar
Pirker R et al (1990) Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil. Int J Cancer 45(5):916–919.
Article
CAS
PubMed
Google Scholar
Quintieri L, Fantin M, Vizler C (2007) Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs. Adv Exp Med Biol 593:95–104.
Article
PubMed
Google Scholar
Raad I et al (2006) Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein. Bioorg Med Chem 14(20):6979–6987.
Article
CAS
PubMed
Google Scholar
Rabindran SK et al (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60(1):47–50.
CAS
PubMed
Google Scholar
Ramachandran C et al (2003) Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines. Int J Cancer 105(6):784–789.
Article
CAS
PubMed
Google Scholar
Reis MA et al (2016) Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction. Phytomedicine 23(9):968–978.
Article
CAS
PubMed
Google Scholar
Robey RW et al (2001) Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res 7(1):145–152.
CAS
PubMed
Google Scholar
Saeed MEM et al (2016) Cytotoxicity of south-African medicinal plants towards sensitive and multidrug-resistant cancer cells. J Ethnopharmacol 186:209–223.
Article
CAS
PubMed
Google Scholar
Saluja R et al (2016) Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: from chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urol Oncol 34(5):225–232.
Article
CAS
PubMed
Google Scholar
Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31(8):1397–1407.
Article
CAS
PubMed
Google Scholar
Scambia G et al (1994) Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34(6):459–464.
Article
CAS
PubMed
Google Scholar
Shi Z et al (2007a) Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Cancer Sci 98(9):1373–1380.
Article
CAS
PubMed
Google Scholar
Shi Z et al (2007b) Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol Rep 17(4):969–976.
MathSciNet
CAS
PubMed
Google Scholar
Shiraga K et al (2001) Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines. J Gastroenterol Hepatol 16(4):460–466.
Article
CAS
PubMed
Google Scholar
Shukla S et al (2007) The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol Cancer Ther 6(12 Pt 1):3279–3286.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sikic BI (2015) Chapter 47 - Natural and acquired resistance to cancer therapies A2. In: John M, Gray JW et al (eds) The molecular basis of cancer (fourth edition). Elsevier Inc, Philadelphia, pp 651–660:e4.
Society., A.C. Cancer Facts & Figures 2016; Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf.
Soenen DR et al (2003) Multidrug resistance reversal activity of key ningalin analogues. Bioorg Med Chem Lett 13(10):1777–1781.
Article
CAS
PubMed
Google Scholar
Tanaka J et al (2002) New polyoxygenated steroids exhibiting reversal of multidrug resistance from the gorgonian Isis hippuris. Tetrahedron 58(32):6259–6266.
Article
CAS
Google Scholar
Tao H, Hwang I, Boger DL (2004) Multidrug resistance reversal activity of permethyl ningalin B amide derivatives. Bioorg Med Chem Lett 14(24):5979–5981.
Article
CAS
PubMed
Google Scholar
Teng YN et al (2016) beta-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Phytomedicine 23(3):316–323.
Article
CAS
PubMed
Google Scholar
Toppmeyer D et al (2002) Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel. Clin Cancer Res 8(3):670–678.
CAS
PubMed
Google Scholar
Torre LA et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108.
Article
PubMed
Google Scholar
Tsuruo T et al (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41(5):1967–1972.
CAS
PubMed
Google Scholar
Turk D et al (2009) Identification of compounds selectively killing multidrug-resistant cancer cells. Cancer Res 69(21):8293–8301.
Article
PubMed
PubMed Central
CAS
Google Scholar
Umsumarng S et al (2017) Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships. Phytomedicine 34(Supplement C):182–190.
Article
CAS
PubMed
Google Scholar
Urbatsch IL et al (1995) P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 270(33):19383–19390.
Article
CAS
PubMed
Google Scholar
van Zanden JJ et al (2005) Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin. Biochem Pharmacol 69(11):1657–1665.
Article
PubMed
CAS
Google Scholar
Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Human Genomics 3(3):281–290.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang C et al (2004a) Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate. Biochem Pharmacol 68(5):843–855.
Article
MathSciNet
CAS
PubMed
Google Scholar
Wang EJ, Barecki-Roach M, Johnson WW (2004b) Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin. J Pharm Pharmacol 56(1):123–128.
Article
CAS
PubMed
Google Scholar
Wang TX, Yang XH (2008) Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Yao Xue Xue Bao 43(5):461–466.
CAS
PubMed
Google Scholar
Weiss J et al (2005) Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 33(11):1580–1583.
Article
CAS
PubMed
Google Scholar
Woehlecke H et al (2003) Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A. Int J Cancer 107(5):721–728.
Article
CAS
PubMed
Google Scholar
Wu CP, Ohnuma S, Ambudkar SV (2011) Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12(4):609–620.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu CP et al (2005) Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J 272(18):4725–4740.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu JY et al (2003) Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani. Eur J Pharmacol 473(1):9–17.
Article
ADS
CAS
PubMed
Google Scholar
Wu Q et al (2014) Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett 347(2):159–166.
Article
CAS
PubMed
Google Scholar
Yamagishi T et al (2013) P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem 288(44):31761–31771.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yan X-J et al (2014) Triterpenoids as reversal agents for anticancer drug resistance treatment. Drug Discov Today 19(4):482–488.
Article
CAS
PubMed
Google Scholar
Yanagisawa T et al (1999) BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma. Br J Cancer 80(8):1190–1196.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoo HH et al (2007) Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. Planta Med 73(5):444–450.
Article
CAS
PubMed
Google Scholar
Yoshida N et al (2006) Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Food Chem Toxicol 44(12):2033–2039.
Article
CAS
PubMed
Google Scholar
Yoshida N et al (2008) Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport. Drug Metab Dispos 36(7):1206–1211.
Article
CAS
PubMed
Google Scholar
Yu J et al (2016) Advances in plant-based inhibitors of P-glycoprotein. J Enzyme Inhib Med Chem 31(6):867–881.
Yu ST et al (2007) Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem Biophys Res Commun 358(1):79–84.
Article
CAS
PubMed
Google Scholar
Zhang S, Morris ME (2003) Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 304(3):1258–1267.
Article
CAS
PubMed
Google Scholar
Zhang S, Yang X, Morris ME (2004) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65(5):1208–1216.
Article
CAS
PubMed
Google Scholar
Zhao X et al (2004) Synthesis and biological evaluation of taxinine analogues as orally active multidrug resistance reversal agents in cancer. Bioorg Med Chem Lett 14(18):4767–4770.
Article
CAS
PubMed
Google Scholar
Zheng LH et al (2008) Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression. Cancer Lett 272(1):102–109.
Article
CAS
PubMed
Google Scholar
Zhou SF et al (2008) Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem 15(20):1981–2039.
Article
CAS
PubMed
Google Scholar
Zhu HJ et al (2006) Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J Pharmacol Exp Ther 317(2):850–857.
Article
CAS
PubMed
Google Scholar